Wallace R. Noel's most recent trade in Colgate-Palmolive Co. was a trade of 96,041 Common Stock done . Disclosure was reported to the exchange on Feb. 13, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Colgate-Palmolive Co. | Noel R. Wallace | Director, Chairman, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2025 | 96,041 | 365,776 (0%) | 0% | 0 | Common Stock | |
| Colgate-Palmolive Co. | Noel R. Wallace | Director, Chairman, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 87.75 per share. | 13 Feb 2025 | 47,324 | 318,452 (0%) | 0% | 87.8 | 4,152,681 | Common Stock |
| Colgate-Palmolive Co. | Noel Wallace R. | Director, Chairman, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 94.61 per share. | 03 Dec 2024 | 954 | 269,735 (0%) | 0% | 94.6 | 90,258 | Common Stock |
| Colgate-Palmolive Co. | Noel R. Wallace | Director, Chairman, President & CEO | Sale of securities on an exchange or to another person at price $ 95.00 per share. | 22 Nov 2024 | 33,333 | 270,689 (0%) | 0% | 95 | 3,166,635 | Common Stock |
| Colgate-Palmolive Co. | Noel R. Wallace | Director, Chairman, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Sep 2024 | 145,696 | 145,696 | - | - | Stock Option (Right to Buy) | |
| Colgate-Palmolive Co. | Noel R. Wallace | Director, Chairman, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Sep 2024 | 20,689 | 307,848 (0%) | 0% | 0 | Common Stock | |
| Colgate-Palmolive Co. | Noel R. Wallace | Director, Chairman, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 105.73 per share. | 12 Sep 2024 | 4,039 | 303,809 (0%) | 0% | 105.7 | 427,043 | Common Stock |
| Colgate-Palmolive Co. | Noel R. Wallace | Director, Chairman, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Feb 2024 | 56,616 | 331,115 (0%) | 0% | 0 | Common Stock | |
| Colgate-Palmolive Co. | Noel Wallace R. | Director, Chairman, President & CEO | Sale of securities on an exchange or to another person at price $ 84.17 per share. | 15 Feb 2024 | 55,486 | 286,881 (0%) | 0% | 84.2 | 4,670,085 | Common Stock |
| Colgate-Palmolive Co. | Wallace Noel R. | Director, Chairman, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Feb 2024 | 55,486 | 0 | - | - | Stock Option (Right to Buy) | |
| Colgate-Palmolive Co. | Wallace Noel R. | Director, Chairman, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 68.16 per share. | 15 Feb 2024 | 55,486 | 356,829 (0%) | 0% | 68.2 | 3,781,926 | Common Stock |
| Colgate-Palmolive Co. | R. Noel Wallace | Director, Chairman, President & CEO | Sale of securities on an exchange or to another person at price $ 84.06 per share. | 15 Feb 2024 | 29,772 | 301,343 (0%) | 0% | 84.1 | 2,502,664 | Common Stock |
| Colgate-Palmolive Co. | Noel R. Wallace | Director, Chairman, President & CEO | Sale of securities on an exchange or to another person at price $ 84.41 per share. | 15 Feb 2024 | 14,462 | 342,367 (0%) | 0% | 84.4 | 1,220,802 | Common Stock |
| Colgate-Palmolive Co. | Noel R. Wallace | Director, Chairman, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Feb 2024 | 50,000 | 55,486 | - | - | Stock Option (Right to Buy) | |
| Colgate-Palmolive Co. | Wallace Noel R. | Director, Chairman, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 68.16 per share. | 12 Feb 2024 | 50,000 | 324,179 (0%) | 0% | 68.2 | 3,408,000 | Common Stock |
| Colgate-Palmolive Co. | Wallace Noel R. | Director, Chairman, President & CEO | Sale of securities on an exchange or to another person at price $ 83.15 per share. | 12 Feb 2024 | 50,000 | 274,179 (0%) | 0% | 83.1 | 4,157,280 | Common Stock |
| Colgate-Palmolive Co. | Wallace R. Noel | Director, Chairman, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 77.47 per share. | 06 Dec 2023 | 1,299 | 274,179 (0%) | 0% | 77.5 | 100,634 | Common Stock |
| Colgate-Palmolive Co. | Noel R. Wallace | Director, Chairman, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Sep 2023 | 206,515 | 206,515 | - | - | Stock Option (Right to Buy) | |
| Colgate-Palmolive Co. | Noel R. Wallace | Director, Chairman, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Sep 2023 | 28,148 | 275,117 (0%) | 0% | 0 | Common Stock | |
| Colgate-Palmolive Co. | Noel R. Wallace | Director, Chairman, President & CEO | Sale of securities on an exchange or to another person at price $ 73.37 per share. | 11 Sep 2023 | 48,627 | 246,969 (0%) | 0% | 73.4 | 3,567,982 | Common Stock |
| Colgate-Palmolive Co. | Noel R. Wallace | Director, Chairman, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Sep 2023 | 48,627 | 0 | - | - | Stock Option (Right to Buy) | |
| Colgate-Palmolive Co. | Noel R. Wallace | Director, Chairman, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 73.00 per share. | 11 Sep 2023 | 48,627 | 295,596 (0%) | 0% | 73 | 3,549,771 | Common Stock |
| Colgate-Palmolive Co. | Noel R. Wallace | Director, Chairman, President & CEO | Sale of securities on an exchange or to another person at price $ 80.66 per share. | 08 May 2023 | 50,000 | 246,619 (0%) | 0% | 80.7 | 4,032,920 | Common Stock |
| Colgate-Palmolive Co. | Noel R. Wallace | Director, Chairman, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 May 2023 | 50,000 | 48,627 | - | - | Stock Option (Right to Buy) | |
| Colgate-Palmolive Co. | Noel R. Wallace | Director, Chairman, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 73.00 per share. | 08 May 2023 | 50,000 | 296,619 (0%) | 0% | 73 | 3,650,000 | Common Stock |
| Colgate-Palmolive Co. | Noel R. Wallace | Director, Chairman, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Feb 2023 | 45,461 | 267,765 (0%) | 0% | 0 | Common Stock | |
| Colgate-Palmolive Co. | Noel R. Wallace | Director, Chairman, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 72.77 per share. | 16 Feb 2023 | 21,146 | 246,619 (0%) | 0% | 72.8 | 1,538,794 | Common Stock |
| Colgate-Palmolive Co. | Noel R. Wallace | Director, Chairman, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Sep 2022 | 322,910 | 322,910 | - | - | Stock Option (Right to Buy) | |
| Colgate-Palmolive Co. | Noel R. Wallace | Director, Chairman, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 72.99 per share. | 04 Aug 2022 | 51,665 | 273,455 (0%) | 0% | 73.0 | 3,771,028 | Common Stock |
| Colgate-Palmolive Co. | Noel R. Wallace | Director, Chairman, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Aug 2022 | 51,665 | 0 | - | - | Stock Option (Right to Buy) | |
| Colgate-Palmolive Co. | Noel R. Wallace | Director, Chairman, President & CEO | Sale of securities on an exchange or to another person at price $ 81.27 per share. | 04 Aug 2022 | 51,665 | 221,790 (0%) | 0% | 81.3 | 4,198,897 | Common Stock |
| Colgate-Palmolive Co. | Noel R. Wallace | Director, Chairman, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Jun 2022 | 50,000 | 51,665 | - | - | Stock Option (Right to Buy) | |
| Colgate-Palmolive Co. | Noel R. Wallace | Director, Chairman, President & CEO | Sale of securities on an exchange or to another person at price $ 79.34 per share. | 06 Jun 2022 | 50,000 | 221,790 (0%) | 0% | 79.3 | 3,966,905 | Common Stock |
| Colgate-Palmolive Co. | Noel R. Wallace | Director, Chairman, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 72.99 per share. | 06 Jun 2022 | 50,000 | 271,790 (0%) | 0% | 73.0 | 3,649,500 | Common Stock |
| Colgate-Palmolive Co. | Noel R. Wallace | Director, Chairman, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Feb 2022 | 73,562 | 260,208 (0%) | 0% | 0 | Common Stock | |
| Colgate-Palmolive Co. | Noel R. Wallace | Director, Chairman, President & CEO | Sale of securities on an exchange or to another person at price $ 79.33 per share. | 17 Feb 2022 | 38,583 | 221,625 (0%) | 0% | 79.3 | 3,060,824 | Common Stock |
| Colgate-Palmolive Co. | Noel R. Wallace | Director, Chairman, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 68.98 per share. | 04 Nov 2021 | 152,809 | 384,899 (0%) | 0% | 69.0 | 10,540,765 | Common Stock |
| Colgate-Palmolive Co. | Noel R. Wallace | Director, Chairman, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Nov 2021 | 152,809 | 100,000 | - | - | Stock Option (Right to Buy) | |
| Colgate-Palmolive Co. | Noel R. Wallace | Director, Chairman, President & CEO | Sale of securities on an exchange or to another person at price $ 77.18 per share. | 04 Nov 2021 | 145,200 | 239,699 (0%) | 0% | 77.2 | 11,206,681 | Common Stock |
| Colgate-Palmolive Co. | Noel R. Wallace | Director, Chairman, President & CEO | Sale of securities on an exchange or to another person at price $ 77.40 per share. | 04 Nov 2021 | 100,000 | 239,699 (0%) | 0% | 77.4 | 7,739,520 | Common Stock |
| Colgate-Palmolive Co. | Noel R. Wallace | Director, Chairman, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 68.98 per share. | 04 Nov 2021 | 100,000 | 339,699 (0%) | 0% | 69.0 | 6,898,000 | Common Stock |
| Colgate-Palmolive Co. | Noel R. Wallace | Director, Chairman, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Nov 2021 | 100,000 | 0 | - | - | Stock Option (Right to Buy) | |
| Colgate-Palmolive Co. | Noel R. Wallace | Director, Chairman, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Sep 2021 | 405,041 | 405,041 | - | - | Stock Option (Right to Buy) | |
| Colgate-Palmolive Co. | Noel R. Wallace | Director, Chairman, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 May 2021 | 25,279 | 0 | - | - | Stock Option (Right to Buy) | |
| Colgate-Palmolive Co. | Noel R. Wallace | Director, Chairman, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 61.93 per share. | 05 May 2021 | 25,279 | 257,057 (0%) | 0% | 61.9 | 1,565,528 | Common Stock |
| Colgate-Palmolive Co. | Noel R. Wallace | Director, Chairman, President & CEO | Sale of securities on an exchange or to another person at price $ 81.03 per share. | 05 May 2021 | 25,279 | 231,778 (0%) | 0% | 81.0 | 2,048,383 | Common Stock |
| Colgate-Palmolive Co. | Noel R. Wallace | Director, Chairman, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Feb 2021 | 28,297 | 231,795 (0%) | 0% | 0 | Common Stock | |
| Colgate-Palmolive Co. | Noel R. Wallace | Director, Chairman, President & CEO | Sale of securities on an exchange or to another person at price $ 78.24 per share. | 18 Feb 2021 | 17 | 231,778 (0%) | 0% | 78.2 | 1,330 | Common Stock |
| Colgate-Palmolive Co. | Noel R. Wallace | Director, Chairman, President & CEO | Sale of securities on an exchange or to another person at price $ 77.30 per share. | 16 Feb 2021 | 2,961 | 203,464 (0%) | 0% | 77.3 | 228,894 | Common Stock |
| Colgate-Palmolive Co. | Noel R. Wallace | Director, Chairman, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Nov 2020 | 25,000 | 25,279 | - | - | Stock Option (Right to Buy) | |
| Colgate-Palmolive Co. | Noel R. Wallace | Director, Chairman, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 61.93 per share. | 17 Nov 2020 | 25,000 | 227,840 (0%) | 0% | 61.9 | 1,548,250 | Common Stock |
| Colgate-Palmolive Co. | Noel R. Wallace | Director, Chairman, President & CEO | Sale of securities on an exchange or to another person at price $ 85.86 per share. | 17 Nov 2020 | 21,446 | 206,394 (0%) | 0% | 85.9 | 1,841,296 | Common Stock |
| Colgate-Palmolive Co. | Noel R. Wallace | Director, Chairman, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Nov 2020 | 31,015 | 50,279 | - | - | Stock Option (Right to Buy) | |
| Colgate-Palmolive Co. | Noel R. Wallace | Director, Chairman, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 61.93 per share. | 09 Nov 2020 | 31,015 | 229,726 (0%) | 0% | 61.9 | 1,920,759 | Common Stock |
| Colgate-Palmolive Co. | Noel R. Wallace | Director, Chairman, President & CEO | Sale of securities on an exchange or to another person at price $ 83.80 per share. | 09 Nov 2020 | 26,886 | 202,840 (0%) | 0% | 83.8 | 2,253,020 | Common Stock |
| Colgate-Palmolive Co. | Noel R. Wallace | Director, Chairman, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 61.93 per share. | 05 Nov 2020 | 16,008 | 212,609 (0%) | 0% | 61.9 | 991,375 | Common Stock |
| Colgate-Palmolive Co. | Noel R. Wallace | Director, Chairman, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Nov 2020 | 16,008 | 81,294 | - | - | Stock Option (Right to Buy) | |
| Colgate-Palmolive Co. | Noel R. Wallace | Director, Chairman, President & CEO | Sale of securities on an exchange or to another person at price $ 83.50 per share. | 05 Nov 2020 | 13,898 | 198,711 (0%) | 0% | 83.5 | 1,160,532 | Common Stock |
| Colgate-Palmolive Co. | Noel R. Wallace | Director, Chairman, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 61.93 per share. | 05 Nov 2020 | 2,977 | 199,179 (0%) | 0% | 61.9 | 184,366 | Common Stock |
| Colgate-Palmolive Co. | Noel R. Wallace | Director, Chairman, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Nov 2020 | 2,977 | 97,302 | - | - | Stock Option (Right to Buy) | |
| Colgate-Palmolive Co. | Noel R. Wallace | Director, Chairman, President & CEO | Sale of securities on an exchange or to another person at price $ 84.04 per share. | 05 Nov 2020 | 2,578 | 196,601 (0%) | 0% | 84.0 | 216,652 | Common Stock |
| Colgate-Palmolive Co. | Noel R. Wallace | Director, Chairman, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Sep 2020 | 377,443 | 377,443 | - | - | Stock Option (Right to Buy) | |
| Colgate-Palmolive Co. | Noel R. Wallace | Director, Chairman, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 64.00 per share. | 05 Aug 2020 | 93,666 | 282,097 (0%) | 0% | 64 | 5,994,624 | Common Stock |
| Colgate-Palmolive Co. | Noel R. Wallace | Director, Chairman, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Aug 2020 | 93,666 | 0 | - | - | Stock Option (Right to Buy) | |
| Colgate-Palmolive Co. | Noel R. Wallace | Director, Chairman, President & CEO | Sale of securities on an exchange or to another person at price $ 76.37 per share. | 05 Aug 2020 | 85,929 | 196,168 (0%) | 0% | 76.4 | 6,562,045 | Common Stock |